Literature DB >> 22684821

Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk.

Odilia Popanda1, Petra Seibold, Ivaylo Nikolov, Christopher C Oakes, Barbara Burwinkel, Sebastian Hausmann, Dieter Flesch-Janys, Christoph Plass, Jenny Chang-Claude, Peter Schmezer.   

Abstract

Base excision repair (BER) removes DNA damage induced by endogenous reactive oxygen species or ionizing radiation, important breast cancer risk factors. Genetic variation associated with impaired BER might thus increase breast cancer risk. Therefore, we assessed risk associations of 123 common single nucleotide polymorphisms (SNPs) in 19 BER genes in 1,639 postmenopausal breast cancer cases and 1,967 controls from the German population-based case-control study MARIE. SNPs were tagging SNPs representing genetic variation across the gene together with potentially functional SNPs. Risk associations were assessed using conditional logistic regression, adjusted for potential breast cancer risk factors. Significant associations between polymorphisms and breast cancer risk were found for one SNP in PARP2 and three SNPs in the mitochondrial DNA polymerase gamma, POLG. A SNP in the promoter region of POLG (rs2856268, A>G) showed a protective effect for homozygous GG carriers (odds ratio 0.81, 95% confidence intervals 0.65-1.00). Joint analysis of an enlarged sample set and haplotype analysis supported the results for POLG. Quantification of POLG mRNA expression in lymphocytes of 148 breast cancer patients revealed higher mRNA levels for rs2856268 GG carriers (p value = 0.038). A luciferase promoter assay showed significant differences between constructs harboring the respective alleles. Taken together, our results suggest that genetic variation in the POLG promoter region affects DNA polymerase gamma levels in mitochondria. This could contribute to the reported increase in mitochondrial mutation frequency resulting in dysfunction and altered breast cancer risk. Risk effects and the functional impact of the POLG promoter variant require further confirmation.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22684821     DOI: 10.1002/ijc.27665

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Association of novel gene polymorphisms RRM1 -756T>C and -269 C>A with breast cancer.

Authors:  Dar-Ren Chen; Chun-Yi Chuang; Buor-Chang Wu; Shun-Fa Yang; Yu-Hsien Peng; Hsiu-Ting Tsai
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

Review 2.  Mitochondrial determinants of cancer health disparities.

Authors:  Aaheli Roy Choudhury; Keshav K Singh
Journal:  Semin Cancer Biol       Date:  2017-05-06       Impact factor: 15.707

3.  Mutational landscape of candidate genes in familial prostate cancer.

Authors:  Anna M Johnson; Kimberly A Zuhlke; Chris Plotts; Shannon K McDonnell; Sumit Middha; Shaun M Riska; Daniel J Schaid; Stephen N Thibodeau; Julie A Douglas; Kathleen A Cooney
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

Review 4.  Spotlight on the relevance of mtDNA in cancer.

Authors:  A Cruz-Bermúdez; R J Vicente-Blanco; E Gonzalez-Vioque; M Provencio; M Á Fernández-Moreno; R Garesse
Journal:  Clin Transl Oncol       Date:  2016-10-24       Impact factor: 3.405

Review 5.  Understanding specific functions of PARP-2: new lessons for cancer therapy.

Authors:  Syed O Ali; Farhaan A Khan; Miguel A Galindo-Campos; José Yélamos
Journal:  Am J Cancer Res       Date:  2016-09-01       Impact factor: 6.166

6.  OGG1 Mutations and Risk of Female Breast Cancer: Meta-Analysis and Experimental Data.

Authors:  Kashif Ali; Ishrat Mahjabeen; Maimoona Sabir; Humera Mehmood; Mahmood Akhtar Kayani
Journal:  Dis Markers       Date:  2015-05-19       Impact factor: 3.434

7.  Polymorphisms in DNA polymerase γ affect the mtDNA stability and the NRTI-induced mitochondrial toxicity in Saccharomyces cerevisiae.

Authors:  Enrico Baruffini; Jessica Ferrari; Cristina Dallabona; Claudia Donnini; Tiziana Lodi
Journal:  Mitochondrion       Date:  2014-11-18       Impact factor: 4.160

8.  A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

Authors:  Petra Seibold; Peter Schmezer; Sabine Behrens; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Dieter Flesch-Janys; Heli Nevanlinna; Rainer Fagerholm; Kristiina Aittomäki; Carl Blomqvist; Sara Margolin; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Diether Lambrechts; Hans Wildiers; Vessela Kristensen; Grethe Grenaker Alnæs; Silje Nord; Anne-Lise Borresen-Dale; Maartje J Hooning; Antoinette Hollestelle; Agnes Jager; Caroline Seynaeve; Jingmei Li; Jianjun Liu; Keith Humphreys; Alison M Dunning; Valerie Rhenius; Mitul Shah; Maria Kabisch; Diana Torres; Hans-Ulrich Ulmer; Ute Hamann; Joellen M Schildkraut; Kristen S Purrington; Fergus J Couch; Per Hall; Paul Pharoah; Doug F Easton; Marjanka K Schmidt; Jenny Chang-Claude; Odilia Popanda
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

9.  BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.

Authors:  Leslie J Burke; Jan Sevcik; Gaetana Gambino; Emma Tudini; Eliseos J Mucaki; Ben C Shirley; Phillip Whiley; Michael T Parsons; Kim De Leeneer; Sara Gutiérrez-Enríquez; Marta Santamariña; Sandrine M Caputo; Elizabeth Santana Dos Santos; Jana Soukupova; Marketa Janatova; Petra Zemankova; Klara Lhotova; Lenka Stolarova; Mariana Borecka; Alejandro Moles-Fernández; Siranoush Manoukian; Bernardo Bonanni; Stacey L Edwards; Marinus J Blok; Thomas van Overeem Hansen; Maria Rossing; Orland Diez; Ana Vega; Kathleen B M Claes; David E Goldgar; Etienne Rouleau; Paolo Radice; Paolo Peterlongo; Peter K Rogan; Maria Caligo; Amanda B Spurdle; Melissa A Brown
Journal:  Hum Mutat       Date:  2018-09-24       Impact factor: 4.878

10.  DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

Authors:  Ana Osorio; Roger L Milne; Karoline Kuchenbaecker; Tereza Vaclová; Guillermo Pita; Rosario Alonso; Paolo Peterlongo; Ignacio Blanco; Miguel de la Hoya; Mercedes Duran; Orland Díez; Teresa Ramón Y Cajal; Irene Konstantopoulou; Cristina Martínez-Bouzas; Raquel Andrés Conejero; Penny Soucy; Lesley McGuffog; Daniel Barrowdale; Andrew Lee; Brita Arver; Johanna Rantala; Niklas Loman; Hans Ehrencrona; Olufunmilayo I Olopade; Mary S Beattie; Susan M Domchek; Katherine Nathanson; Timothy R Rebbeck; Banu K Arun; Beth Y Karlan; Christine Walsh; Jenny Lester; Esther M John; Alice S Whittemore; Mary B Daly; Melissa Southey; John Hopper; Mary B Terry; Saundra S Buys; Ramunas Janavicius; Cecilia M Dorfling; Elizabeth J van Rensburg; Linda Steele; Susan L Neuhausen; Yuan Chun Ding; Thomas V O Hansen; Lars Jønson; Bent Ejlertsen; Anne-Marie Gerdes; Mar Infante; Belén Herráez; Leticia Thais Moreno; Jeffrey N Weitzel; Josef Herzog; Kisa Weeman; Siranoush Manoukian; Bernard Peissel; Daniela Zaffaroni; Giulietta Scuvera; Bernardo Bonanni; Frederique Mariette; Sara Volorio; Alessandra Viel; Liliana Varesco; Laura Papi; Laura Ottini; Maria Grazia Tibiletti; Paolo Radice; Drakoulis Yannoukakos; Judy Garber; Steve Ellis; Debra Frost; Radka Platte; Elena Fineberg; Gareth Evans; Fiona Lalloo; Louise Izatt; Ros Eeles; Julian Adlard; Rosemarie Davidson; Trevor Cole; Diana Eccles; Jackie Cook; Shirley Hodgson; Carole Brewer; Marc Tischkowitz; Fiona Douglas; Mary Porteous; Lucy Side; Lisa Walker; Patrick Morrison; Alan Donaldson; John Kennedy; Claire Foo; Andrew K Godwin; Rita Katharina Schmutzler; Barbara Wappenschmidt; Kerstin Rhiem; Christoph Engel; Alfons Meindl; Nina Ditsch; Norbert Arnold; Hans Jörg Plendl; Dieter Niederacher; Christian Sutter; Shan Wang-Gohrke; Doris Steinemann; Sabine Preisler-Adams; Karin Kast; Raymonda Varon-Mateeva; Andrea Gehrig; Dominique Stoppa-Lyonnet; Olga M Sinilnikova; Sylvie Mazoyer; Francesca Damiola; Bruce Poppe; Kathleen Claes; Marion Piedmonte; Kathy Tucker; Floor Backes; Gustavo Rodríguez; Wendy Brewster; Katie Wakeley; Thomas Rutherford; Trinidad Caldés; Heli Nevanlinna; Kristiina Aittomäki; Matti A Rookus; Theo A M van Os; Lizet van der Kolk; J L de Lange; Hanne E J Meijers-Heijboer; A H van der Hout; Christi J van Asperen; Encarna B Gómez Garcia; Nicoline Hoogerbrugge; J Margriet Collée; Carolien H M van Deurzen; Rob B van der Luijt; Peter Devilee; Edith Olah; Conxi Lázaro; Alex Teulé; Mireia Menéndez; Anna Jakubowska; Cezary Cybulski; Jacek Gronwald; Jan Lubinski; Katarzyna Durda; Katarzyna Jaworska-Bieniek; Oskar Th Johannsson; Christine Maugard; Marco Montagna; Silvia Tognazzo; Manuel R Teixeira; Sue Healey; Curtis Olswold; Lucia Guidugli; Noralane Lindor; Susan Slager; Csilla I Szabo; Joseph Vijai; Mark Robson; Noah Kauff; Liying Zhang; Rohini Rau-Murthy; Anneliese Fink-Retter; Christian F Singer; Christine Rappaport; Daphne Geschwantler Kaulich; Georg Pfeiler; Muy-Kheng Tea; Andreas Berger; Catherine M Phelan; Mark H Greene; Phuong L Mai; Flavio Lejbkowicz; Irene Andrulis; Anna Marie Mulligan; Gord Glendon; Amanda Ewart Toland; Anders Bojesen; Inge Sokilde Pedersen; Lone Sunde; Mads Thomassen; Torben A Kruse; Uffe Birk Jensen; Eitan Friedman; Yael Laitman; Shani Paluch Shimon; Jacques Simard; Douglas F Easton; Kenneth Offit; Fergus J Couch; Georgia Chenevix-Trench; Antonis C Antoniou; Javier Benitez
Journal:  PLoS Genet       Date:  2014-04-03       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.